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(ENG)Abstract Background: Vestibular dysfunction has been long described in patients with migraine;
this relation has been addressed as vestibular migraine. The pathophysiology as well as the periph-
eral or central localization of this deﬁcit is unclear. Cervical vestibular evoked myogenic potential
(cVEMP) is a validated method to test saccular function and vestibulocollic pathway.
Objectives: The current work was designed to assess the characteristics of cVEMP response in
patients with vestibular migraine and compare them with the results of healthy controls, and to ﬁnd
out if the cVEMP could be useful as a complementary tool for testing vestibular function in vestibu-
lar migraine.
Methods: Twenty ﬁve patients with deﬁnite vestibular migraine were involved as a study group.
Twenty healthy volunteers of comparable age and sex were taken as a control group. The amplitude
and latency of cVEMP were measured. Electronystagmography (ENG) test battery including calo-
ric testing was done.
Results: Our study demonstrated signiﬁcant reduction in cVEMP amplitudes, and more fre-
quently absent response in patients with vestibular migraine compared to healthy controls. There
was no correlation between cVEMP amplitudes and caloric testing. ENG tests showed peripheral
vestibular lesion in 36% of patients, central lesion in 16%, mixed lesion in 4%.
Conclusion: cVEMP is a useful complementary tool for testing vestibular function in vestibular
migraine. Reduced cVEMP amplitude or absent response were the most frequent features in
vestibular migraine. The saccule and or the sacculo-collic pathway are affected in vestibular
migraine, with more tendencies for peripheral vestibular dysfunction in our patient group.
ª 2015 Egyptian Society of Ear, Nose, Throat and Allied Sciences. Production and hosting by Elsevier
B.V. All rights reserved.1. Introduction
Migraine has long been recognized to be associated with
several vestibular syndromes, and sometimes vertigo is the car-
dinal symptom. This type of migraine is called vestibulared.
140 E.S. Mohamed et al.migraine (VM).1,2 Vestibular migraine has gained recognition
as a distinct clinical entity in recent years. VM has a 6–10%
incidence, and is one of the most common diagnoses in dizzi-
ness units, but it still not included in the International
Headache Society (IHS) criteria as a subgroup of migraine.3
Neuhauser et al. have proposed operational diagnostic criteria
for vestibular migraine.4,5 The vestibular symptoms in VM can
occur before the migraine headache in a similar pattern as an
aura phenomenon, during the headache, or completely
independent of the headache. Many also report a chronic sub-
tle feeling of vertigo and disequilibrium all the time, with
exacerbations during migraine attacks.6 The pathophysiology
of the VM is unclear, it could be localized anywhere in the
vestibular system. Previous studies of VM describe a variety
of abnormal vestibular ﬁndings, some indicating dysfunction
in the central vestibular system, and others in the peripheral
vestibular system.7–9 The sensation of vertigo in VM patients
may arise from a decreased or an increased activation of the
vestibular system, either peripheral, or central, generating a
tonic imbalance between these structures.6
Functional abnormalities of the vestibular system in
vestibular migraine were tested in different studies; recently it
was evaluated by the cervical vestibular evoked myogenic
potential (cVEMP).6,10–12 cVEMP is a short-latency myogenic
response which is evoked by sound and recorded from neck
muscles. The currently understood cVEMP was ﬁrst described
by Colebatch and Halmagyi (1992), and Colebatch et al.
(1994).13,14 Since then, cVEMP have become a standard clini-
cal test of otolith (predominantly saccular) function. The con-
ventional method for recording the cVEMP involves
measuring electromyographic activity from surface electrodes
placed over the tonically-activated sternocleidomastoid mus-
cles. The cVEMP is thus a manifestation of the vestibulo-collic
reﬂex. However, recent research has shown that VEMP can
also be recorded from the extraocular muscles, using surface
electrodes placed near the eyes. These ocular VEMP
(oVEMP) are a manifestation of the vestibule-ocular reﬂex.15
cVEMP have been applied in cases of peripheral vestibular dis-
eases such as Meniere’s disease, vestibular neuritis, vestibular
schwannomas, and superior semicircular canal dehiscence.16–20
However studies on disorders of central vestibular origins are
not only rare, they are also generally inconclusive.21–23
There is a growing amount of interest in cVEMP studies on
migraine in the recent years with different results. Liao and
Young (2004), and Boldingh et al. (2011) have reported absent
or delayed cVEMP,12,16 whereas Baier and Dieterich (2009),
Allena et al. (2007) and Roceanu et al. (2008) have found
cVEMP of normal latency but, reduced amplitude.11,10,24
Kandemir et al. (2012) recorded normal values of p13, n23
latencies, and amplitudes.25
The aim of the present study is to assess characteristics of
cVEMP response in patients with vestibular migraine and
compare them with the results of healthy controls, and to ﬁnd
out if the cVEMP could be useful as a complementary tool for
testing vestibular function in vestibular migraine.
2. Methods
The study was conducted in the audiology clinic, Assiut
University, Egypt from 2013 to 2014. The study protocol
was approved by the local ethics committee. Informed consentwas obtained from all participants. Twenty ﬁve patients with
VM (14 female and 11 male; mean age 24.6 ± 6.75 with an
age range of 19–40 years) were diagnosed to have deﬁnite
VM according to the criteria of Neuhauser and colleagues4,5:
(1) Recurrent episodic vestibular symptoms of at least moder-
ate intensity. (2) Current or previous history of migraine
according to criteria of the International Headache Society.26
(3) One of the following migrainous symptoms during at least
two vertiginous attacks: migrainous headache, photophobia,
phonophobia, visual or other auras. (4) Other causes ruled
out by appropriate investigations. Triptans, antiepileptic drugs
and vestibular suppressant drugs were stopped 1 week before
testing. The mean disease duration was 1.65 years. In all
patients, vertigo attacks were characterized by spinning sensa-
tion, 72% had positional symptoms, and 16% had unsteadi-
ness. In 9 (36%) patients, vertigo attacks associated with
headaches, in six (24%) patients, vertigo occurred after the
headache; in four (16%) it preceded the headache. In six
(24%) vertigo attacks not related to headaches and sometimes
associated with headaches. Headache was hemicranial in 15
patients, holocranial (affecting the whole head) in seven
patients and in three patients it may be hemicranial and some-
times holocranial. Nausea, and or vomiting were reported to
be present in 19 patients (76%) during the vertigo attacks or
headaches. Hearing loss, middle ear pathology and other
vestibular disorders were exclusion criteria.
The control group included age and sex matched 20 healthy
volunteers (14 female and 6 male, mean ages 23.4 ± 5.0) with
no history of vestibular symptoms or migraine. Comparing age
and gender between study and control groups revealing no sig-
niﬁcant difference, P= 0.086 for age; P= 0.258 for sex). All
subjects were submitted to full history taking, otological exam-
ination, and neurological examination, which are free in all
subjects. Audiological evaluation was performed for both
groups to ensure normal hearing sensitivity. Two channel
audiometer Madsen model, Orbiter 922 and interacoustics
AZ 26 tympanometer were used.
2.1. cVEMP recording
Testing of cVEMP was recorded by interacoustics, EP 15 ver-
sion 3.03; it was done in the interictal period (absence of
migraine headache and vertigo attacks for at least, the last
two days). VEMP test was recorded in all subjects while turn-
ing their head to the opposite side to activate the stern-
ocleidomastoid (SCM) muscle. The electromyography was
recorded with surface electrodes mounted in the middle third
of SCM on the tested side. The reference electrode was placed
on the ipsilateral mastoid. Tone burst of 500 Hz was presented
to the tested ear at intensity of 100 dB nHL with 5.1/s. stimulus
rate. Four millisecond (ms) rise/fall time was used with a pla-
teau time of 2.0 ms. The analysis time was 80 ms and the ﬁlter
setting was 10–750 Hz. The latencies of peaks p13 and n23 and
peak to peak amplitude were measured. Since the amplitude of
the p13–n23 response is largely determined by the level of tonic
SCM contraction,27 the EMG activities were monitored during
recording, and subjects received a visual feedback so as to
maintain muscle activities at constant level. To normalize the
raw VEMP magnitudes, an EMG scaling was done by dividing
the raw amplitude for each recording on the mean rectiﬁed
EMG activity from the pre-stimulus period. To determine
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asymmetry ratio (AR) was calculated using the following for-
mula: AR%= 100(Al  As)/(Al + As), Where Al and As are
the larger and smaller, amplitudes obtained from stimulating
each ear.19
2.2. ENG testing
A full ENG test battery was done by Micromedical tech.
(Meta 4 version 8.1), using monopolar electrode montage,
and it included a search for nystagmus both with and without
ﬁxation, with horizontal and vertical gaze deviation, and with
a post-head shaking test. Also, nystagmus was studied using
both the Dix–Hallpike test (positioning test) for the right
and left side, and positional tests including the supine, head
right and head left, and right lateral and left lateral positions.
An assessment of saccades, smooth pursuit, and optokinetic
nystagmus was also done. In addition, caloric function was
studied with the use of alternate bithermal caloric irrigation
with water at 30 C and 44 C. A difference of 20% was con-
sidered unilateral caloric weakness and the magnitude of a nys-
tagmus of a slow-component velocity of 6 degree/s was
considered signiﬁcant during positional, and post-head shake
testing, or nystagmus tests.
Data collected, and analyzed by means of statistical soft-
ware package for social sciences (SPSS) version 21. Data
expressed as mean, Standard deviation, number, and percent-
age. Mann whitney test was used to determine signiﬁcance for
numeric variable. Chi Square was used to determine signiﬁ-
cance for categorical variable. Spearman Rank correlation test
was used for correlations between groups. A difference was
considered to be statistically signiﬁcant (*) when the probabil-
ity (P) value was 60.05.3. Results
Patients with vestibular migraine showed signiﬁcant lower
p13–23 mean amplitudes on both sides compared to controls
(P< 0.05 for each side) (Table 1). Sixteen patients with
vestibular migraine (64%) had signiﬁcantly reduced VEMP
amplitude; lower than the lower limit of the 95% CI (conﬁ-
dence interval) of the controls. Four of them (16%) had
reduced amplitude on the right, four (16%) in the left and eight
(32%) had reduced amplitudes bilaterally. VEMP response
were present in all normal subjects but six of the 25 patients
(24%) with vestibular migraine had absent VEMP response,
four of them (16%) had no waveform on the right side, one
patient (4%) had no waveform on the left side, and one patientTable 1 VEMP amplitude and threshold in vestibular migraine pat
Patients Contro
Mean SD Mean
p13 n23 Amplitude right (ms) 0.82 0.41 1.17
p13 n23 Amplitude left (ms) 0.81 0.47 1.18
Asymmetry ratio 0.16 0.11 0.079
CI: conﬁdence interval.
* P value 60.05.(4%) had no waveform bilaterally. Collectively, 19 (76%) of
the 25 patients showed abnormal VEMP response (either
reduced amplitude, or absent response, or both).
Studying the relation of amplitudes of both sides, the asym-
metry ratio compared between migraine patients, and controls
showed a statistically signiﬁcant difference (P= 0.005)
(Table 1), which means a reduced amplitude in one side than
the other in patients with vestibular migraine (Fig. 1). The
asymmetry ratio could not be recorded in six patients because
of absent waveform either unilaterally or bilaterally. It was
recorded in 19 patients, and in 14 of them (74%), it was more
than the upper limit of the 95% CI (0.108) of the controls.
With regard to latencies, a mean p13 of 16.94 ms
(SD ± 2.15) and an n23 of 26.5 ms (SD ± 2.89) were calcu-
lated for the right side in patients with vestibular migraine.
On the left side, they had a mean of 17.69 ms (SD ± 3.0)
and 27.26 ms (SD ± 3.95) for n23. In the control group, the
latency for p13 on the right side was 16.79 ms (SD ± 2.92)
and on the left side 16.23 ms (SD ± 2.29). The latency for
n23 on the right was 25.43 ms (SD± 3.49) and 24.9 ms
(SD ± 4.3) on the left. There was neither a group difference
of the latencies for the p13 nor the n23 on both sides (p13 right
side P= 0.854, left side P= 0.084, n23 right side P= 0.301,
left side P= 0.068) (Fig. 2). However six patients (24%) had
more prolonged latency than the upper limit of 95% CI of
the control group.
In patients with vestibular migraine, 16 out of 25 partici-
pants (64%) had abnormalities in at least one of the ENG tests
(Table 2). Positioning and positional tests revealed signiﬁcant
nystagmus in 52% of patients, which included direction ﬁxed
or geotropic direction changing nystagmus and two patients
only showed a geotropic direction changing nystagmus. The
second abnormality was presence of unilateral caloric weak-
ness (20%) that is followed by abnormal post head-shaking
(16%). In addition 12% had abnormal saccade, 12% had
abnormal pursuit, and 8% had abnormal OPK. There was
no evidence of spontaneous, or gaze nystagmus in the study
group. ENG test results in the control group showed no signiﬁ-
cant nystagmus, symmetrical caloric response, and normal
oculomotor test.
To test an association between the cVEMP amplitude, and
the caloric function, Spearman Rank correlation test was per-
formed, showing no signiﬁcant correlation on the right or left
side (right side r= 0.022; p= 0.894, left side r= 0.219;
p= 0.157).
From ENG results, peripheral vestibular system lesion
(up to the root entry zone) was diagnosed in 36% of patients,
central lesion in 16%, mixed lesion in 4%, and non-localizing
in 8%.ients and controls.
ls 95% CI P-value
SD Lower limit Upper limit
0.72 0.84 1.50 0.046*
0.66 0.86 1.49 0.044*
0.06 0.049 0.108 0.005*
Figure 1 cVEMP recorded from a patient with vestibular migraine from the right and left sides. The corrected amplitude in the right side
is reduced in comparison to the left side, the asymmetry ratio is 0.26.
0
5
10
15
20
25
30
controls vesbular migraine
V
EM
P 
La
te
nc
ie
s
p13 right
n23 right
p13 le
n23 le
Figure 2 VEMP latencies (mean and standard deviation) of the p13 and n23 in patients with vestibular migraine compared to controls.
No signiﬁcant difference was seen.
Table 2 ENG ﬁndings in patients with vestibular migraine.
ENG tests Abnormal (no) (%)
Spontaneous nystagmus test 0 (0)
Gaze nystagmus test 0 (0)
Post head shaking test 4 (16)
Positioning & positional test 13 (52)
Unilateral caloric weakness 5 (20)
Saccade test 3 (12)
Pursuit test 3 (12)
Optokinetic test 2 (8)
ENG: electronystagmography.
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Cervical VEMP was successfully recorded from all control
groups emphasizing that this potential is a reliable addition
to the vestibular testing battery. This agrees withWelgampola and Colebatch, who reported presence of
VEMP response in all normal subjects under the age of 60.
After the six decade the amplitude of the reﬂex decreases pro-
gressively by 25–30% per decade.28
In this study, 24% of patients with vestibular migraine
showed absent cVEMP response. Our results are in line with
Boldingh et al. who reported that absent cVEMP response
was more frequent among vestibular migraine patients (44%)
and patients suffering from ordinary migraine (25%) than in
healthy controls (3%).6 The authors suggest that the absent
response indicates a vestibulocollic dysfunction in vestibular
migraine. Vitkovic et al. also addressed absent cVEMP
response in 19.2% in patients with migraine related dizziness.7
We found in the present study that 64% patients with VM
showed reduced cVEMP amplitudes compared to those of
sex and age matched controls. These results agree with Baier
and Dieterich who reported that 68% of patients with VM
showed reduced cVEMP amplitude and referred these results
to saccular or saccular pathway dysfunction in patients with
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Allena et al. in patients with migraine; they suggest that this
change was due to reduced serotonergic control of the saccular
reﬂex pathways in the brainstem.10 However other studies as
Shalaby et al. reported no signiﬁcant difference as regards
p13–n23 amplitude between patients with VM and controls.29
Alpini et al. attributed the variability in amplitude results
between studies to a wide range of absolute amplitude
measurements which depends greatly on the EMG level of
sternomastoid contraction.30 To overcome this, corrected
amplitudes and asymmetry ratio were used in our study. To
correct the amplitudes, the raw amplitudes were divided by
the mean rectiﬁed EMG activity from the prestimulus period
to correct for differences in muscle activation. Side to side
differences in corrected reﬂex amplitudes were expressed as
an asymmetry ratio (AR), it has been suggested that the most
cautious interpretation of the potentials seems to be their abil-
ity to identify the asymmetry between left and right sides and
therefore to suggest the likely side of the pathology.31 The
marked intersubject variability of absolute amplitude values
is diminished by using this relative amplitude measurement.
In the present study the AR of the control group subjects differ
signiﬁcantly from that of VM patients (Table 1). Iwasaki et al.
reported that AR of amplitude might be a good reﬂectance of
unilateral malfunction than the raw values.32
There was neither a group difference of the latencies for the
p13 nor the n23 on both sides between VM patients and
healthy controls. This agrees with other studies as Baier and
Dieterich (2009) and Allena et al. (2007),11,10 although, some
studies found signiﬁcant delay in p13 and n23 latencies in
VM patients without amplitude reduction.29,12 Most of the
previous studies addressed cVEMP abnormalities in VM
patients, either prolonged latency, or reduced amplitude,
others reported absence of the response.6,7,10–12,29 However,
more recent work by Taylor et al. and Kandemir et al.
reported no abnormalities in cVEMP response.33,25
Therefore, the ﬁndings in the literature with regards to VM
and cVEMP do not appear to be homogenous. This is because
migraine is not a single disease entity and its pathophysiologi-
cal mechanisms are areas for intense researches.
Current concept considered the migraine as an inherited
vulnerability to a hyperexcitable cerebral cortex. Various
stimuli may trigger episodes of cortical spreading depression,
which in turn, initiates the process of localized neurogenic
inﬂammation and sensitization of both the peripheral and
central afferent circuitry, leading to migraine aura and
activation of the trigeminovascular system.34 Since the
vestibular nuclei receive noradrenergic ﬁbers from the locus
coeruleus and serotonergic afferents from the dorsal raphe
nucleus, it is likely that activation of this pathway during
a migraine episode activates the central vestibular process-
ing.35 Dieterich and Brandt suggested that the processes in
patients with vestibular migraine seem to affect both brain-
stem, and peripheral vestibular structures.36 Celebisoy et al.
reported higher incidence of peripheral vestibular dysfunc-
tion than central.37 The peripheral vestibular dysfunction
may be related to hypoperfusion-induced ischemia of the
labyrinthine structures, or serotonergic induced
extravasation.11
It was suggested from literature with regards to vestibular
electropathophysiology, that cVEMP latencies weredelayed in brainstem disorders, but not in peripheral dysfunc-
tion, this were attributed to slowing of conduction along the
vestibulospinal pathways consequent to demyelination. While
the reduction in amplitudes depends on peripheral vestibular
dysfunction.38 The signiﬁcant reduction in cVEMP ampli-
tudes, raised asymmetry ratio, and unaffected latencies are
likely to suggest tendency for peripheral vestibular dysfunction
in our patients group.
ENG is an important vestibular function test used to
study site of lesion. A full test battery was done, 64% of
vestibular migraine patients showed abnormality in at least
one of the ENG tests. Other studies on vestibular migraine
patients reported ENG ﬁndings in 55%, 73%, 75.6% of their
patients groups.39,40,9 Positional nystagmus was the most fre-
quent ﬁnding in VM patients, it was recorded in 52% of the
study group, this result agreed with Hazzaa et al.41 who
reported that positional nystagmus was the commonest ﬁnd-
ing and was recorded in 60% of VM subjects. In our study
group, 20% showed unilateral caloric weakness. Our results
consisted with other studies which reported unilateral caloric
abnormalities in 20%, 25%, 20.8%.42,11,25 However, in a
study performed by Taylor et al.33 caloric proﬁle was normal.
On the other hand, correlation analysis showed that the
results of the caloric tests were not correlated with cVEMP
amplitudes, this result agreed with Kandemir et al. and
Baier and Dieterich.25,11 The lack of correlation between
Caloric test, and cVEMP results, because they assess different
function of the vestibular system, with different vulnerability
of the labyrinthine structures for ischemia, or serotonergic
induced extravastion.22,11
According to ENG, peripheral vestibular system lesion was
diagnosed in 36% of patients, central lesion in 16%, mixed
lesion in 4%, and non-localizing in 8%. These results also sug-
gest tendency for more affection of the peripheral vestibular
system in our patients group.
The wide variation in results of cVEMP parameter study
and localization of site of lesion in patients with vestibular
migraine reﬂect that vestibular migraine is a heterogenous
entity. It can affect peripheral, and or central vestibular
system.
In conclusion, our study demonstrated reduction in
cVEMP amplitudes, absent response, and insigniﬁcant shift
of latencies in patients with vestibular migraine compared to
healthy controls. The saccule, and or the sacculo-collic path-
way are affected, with more tendencies for peripheral vestibu-
lar dysfunction in our patient group. cVEMP could be a useful
complementary tool for testing vestibular function in vestibu-
lar migraine patients.
4.1. Recommendations
We advice to do vestibular rehabilitation therapy (VRT) for
saccular dysfunction in VM patients with impaired VEMP
response. Further study, comparing the effect of VRT for sac-
cular dysfunction in VM patients, with and without impaired
VEMP response is recommended.Financial disclosures
No.
144 E.S. Mohamed et al.Conﬂict of interest
None.
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